“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”. 2022. Journal of Pharmaceutical Negative Results, December, 5734-43. https://www.pnrjournal.com/index.php/home/article/view/5581.